KN035 in Patients With Advanced Multiple Primary Tumors
NCT04182789
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Multiple Primary Neoplasm
Interventions
DRUG:
KN035
Sponsor
RenJi Hospital